Mar 03, 2013This paper, written by T. S. Rangarajan and Anand Vijaykumar of TATA Consultancy Services, offers the pharmaceutical industry an Intelligent Edge Layer (IEL) that would reside between the RFID infrastructure and the existing Clinical Trial Management (CTM) systems, handling the flow of
data during drug development.
RFID in Clinical Trials
SEND IT YOUR WAY
ASK THE EXPERTS
ASK A QUESTION FOR OUR EXPERTS
ASK THE EXPERTS
View previous question answers »